Fibroid drug hair loss study canceled before launch
NCT ID NCT06058728
Summary
This study aimed to track hair changes in women taking Oriahnn for uterine fibroids. Researchers planned to follow 1,600 women for two years to understand how often hair loss occurs, when it starts, and if it improves. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (UF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dorsata /ID# 252675
Arlington, Virginia, 22201-5330, United States
Conditions
Explore the condition pages connected to this study.